华大智造:公司2024年度环境、社会及公司治理(ESG)报告(英文版)

MGI TECH CO., LTD.
Leading Life Science Innovation
MGI TECH CO., LTD.
Environmental, Social and
Governance (ESG) Report
Contents
Message From Chairman 01
About MGI Tech Sustainable Development Leading Life Science Innovation Advancing Life Science Tools for
Transform Future Healthcare
Company Profile 03 Sustainable Development Management 11 Enhancing the Accessibility of Genomics 29 R&D Innovation 51
Company Milestones 05 Key ESG Risks and Opportunities 15 Empowering a Healthy Future 31 Quality Management 63
Company Awards 07 Tools for Measuring Sustainable Development 24 Driving Sustainable Practices 38 Global Services 69
Sustainable Development Strategy 25 Jointly Building an Industrial Ecosystem 47 Sustainable Supply Chain 73
Leader in Compliance Governance Value Growth Partner Guardian of Our Environment Appendices 133
Corporate Governance 77 Employee Employment and Management 95 Environmental Management 115 Appendix I: About the Report 133
Operational Compliance 79 Employee Compensation and Benefits 99 Responding to Climate Change 116 Appendix II: Sustainability Performance 136
Risk Management 85 Employee Career Development and Training 105 Biodiversity Conservation 121 Appendix III: Index of Indicators 141
Data Security and Privacy Protection 87 Occupational Health and Safety 108 Resource Utilization 123 Appendix IV: List of Laws and Regulations 143
Fulfilling Social Responsibility 111 Waste Management 125 Appendix V: Key Annotations 145
Green Operations 128
Feedback 146
Message From
Chairman About MGI Tech Sustainable Development Leading Life Science Advancing Life Science Tools Leader in Compliance Value Growth Guardian of Our Appendices
Transform Innovation for Future Healthcare Governance Partner Environment
Message From Chairman
In this era filled with both challenges and opportunities, MGI Tech firmly believes that technology has the
power to transform the world and drive progress in the life sciences. Driven by our shared vision of promot-
ing "health, longevity, beauty, wisdom, and happiness" for all humanity, we are dedicated to becoming a
global leader in developing and promoting advanced life science tools for future healthcare.
We continuously advance R&D and industrial applications of underlying technologies in life sciences, dedi-
cated to delivering innovative solutions for global scientific research and real-world needs. Thanks to our
technological accumulation and ongoing innovation, we have become the world's first company to offer
large-scale commercial mass production of both "short read length" and "long read length" sequencing
products, achieving significant advancements in accuracy and sequencing throughput. StandardMPS 2.0, Wang Jian
our next-generation high-throughput sequencing reagent, has elevated sequencing quality to an Chairman